We believe that the interaction of HBx and SIRT4 during viral infection (HBV infection in this case) and their roles on carcinogenesis deserve further studies, which may provide insights for the development of therapeutics against HBV-induced HCC. The gene discussed is SIRT4; the disease is hepatocellular carcinoma.